NEURIZON THERAPEUTICS LIMITED - Announcements

2.78%

7.0¢

Market Cap $53.73M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NEURIZON NUZ-001 OLE CONFIRMS SAFETY SIGNALS

Announcements

Filter Results

All Price Sensitive Only

NUZ	Ethics Approval Received for NUZ-001 Oral Liquid P1 Study	PRICE SENSITIVE	13/05/26	284.8KB	Share
NUZ	Final Director's Interest Notice		12/05/26	331.98KB	Share
NUZ	Initial Director's Interest Notice		12/05/26	351.01KB	Share
NUZ	Australian Microcap Investment Conference Presentation		11/05/26	18.86MB	Share
NUZ	Neurizon Strengthens Board for the Next Growth Phase		08/05/26	297.39KB	Share
NUZ	Change of Director's Interest Notices		04/05/26	269KB	Share
NUZ	Neurizon investor briefing presentation		30/04/26	2.32MB	Share
NUZ	Application for quotation of securities - NUZ		30/04/26	15.72KB	Share
NUZ	Appendix 4C & Quarterly Update	PRICE SENSITIVE	30/04/26	763.2KB	Share
NUZ	Section 708A Cleansing Statement		21/04/26	305.95KB	Share
NUZ	Application for quotation of securities - NUZ		21/04/26	15.71KB	Share
NUZ	Neurizon Investor Briefings Invitation		16/04/26	285.88KB	Share
NUZ	Placement of Entitlement Offer Shortfall	PRICE SENSITIVE	16/04/26	293.22KB	Share
NUZ	Investor Presentation - April 2026		10/04/26	1.51MB	Share
NUZ	Section 708A Cleansing Statement		01/04/26	305.53KB	Share
NUZ	Application for quotation of securities - NUZ		01/04/26	15.78KB	Share
NUZ	NUZ-001 Data Shows Multi-Pathway Protein Clearance	PRICE SENSITIVE	01/04/26	420.88KB	Share
NUZ	Change of Director's Interest Notices x4		26/03/26	1.06MB	Share
NUZ	Notification of Expiry of NUZOA Listed Options		20/03/26	837.01KB	Share
NUZ	Neurizon presents at HEALEY ALS Platform Trial Webinar		20/03/26	2.31MB	Share
NUZ	Section 708A Cleansing Statement		19/03/26	308.29KB	Share
NUZ	Application for quotation of securities - NUZ		19/03/26	15.93KB	Share
NUZ	Neurizon announces leadership transition	PRICE SENSITIVE	16/03/26	255.53KB	Share
NUZ	Preclinical Data in Huntington's Disease Presented at ASENT		05/03/26	478.63KB	Share
NUZ	Notification of cessation of securities - NUZ		04/03/26	12.86KB	Share
NUZ	Drawdown of tranche one of strategic financing facility		27/02/26	165.7KB	Share
NUZ	Notification regarding unquoted securities - NUZ		27/02/26	19.29KB	Share
NUZ	Cleansing Statement - Section 708A(12C)(e)		27/02/26	528.53KB	Share
NUZ	Application for quotation of securities - NUZ		27/02/26	16.2KB	Share
NUZ	Section 708A Cleansing Statement		27/02/26	216.27KB	Share
NUZ	Neurizon Initiates Dosing in HEALEY ALS Platform Trial	PRICE SENSITIVE	26/02/26	322.45KB	Share
NUZ	Appendix 4D - Half-year Financial Report - 31 December 2025	PRICE SENSITIVE	25/02/26	630.09KB	Share
NUZ	Results of General Meeting		20/02/26	398.66KB	Share
NUZ	General Meeting Presentation		20/02/26	4.43MB	Share
NUZ	Change of Director's Interest Notice		03/02/26	273.1KB	Share
NUZ	Appendix 4C & Quarterly Update	PRICE SENSITIVE	30/01/26	699.76KB	Share
NUZ	Neurizon secures $6million R&D Tax Incentive Rebate	PRICE SENSITIVE	29/01/26	228.97KB	Share
NUZ	Application for quotation of securities - NUZ		29/01/26	15.9KB	Share
NUZ	Neurizon Completes Entitlement Offer	PRICE SENSITIVE	27/01/26	260.87KB	Share
NUZ	Change of Director's Interest Notice		23/01/26	274.39KB	Share
NUZ	Notification of cessation of securities - NUZ		23/01/26	12.9KB	Share
NUZ	Notice of General Meeting/Proxy Form		21/01/26	903.87KB	Share
NUZ	Global Trademark Protection Secured Across Key Markets	PRICE SENSITIVE	20/01/26	195.44KB	Share
NUZ	Investor webinar presentation		15/01/26	2.52MB	Share
NUZ	Notice of a Shareholder webinar		08/01/26	210.23KB	Share
NUZ	Becoming a substantial holder		07/01/26	273.11KB	Share
NUZ	Notification of cessation of securities - NUZ		06/01/26	12.93KB	Share
NUZ	Entitlement Offer Opens & Despatch of Offer Booklet		05/01/26	4.6MB	Share
NUZ	Section 708A Cleansing Statement		02/01/26	228.17KB	Share
NUZ	Regulatory and Development Update	PRICE SENSITIVE	02/01/26	182.9KB	Share
NUZ	Change of Director's Interest Notices x4		02/01/26	1.09MB	Share
NUZ	Application for quotation of securities - NUZ		31/12/25	14.69KB	Share
NUZ	Section 708A Cleansing Statement		23/12/25	231.1KB	Share
NUZ	Application for quotation of securities - NUZ		23/12/25	15.82KB	Share
NUZ	Notice under s708AA(2)(f)		23/12/25	236.44KB	Share
NUZ	Proposed issue of securities - NUZ		23/12/25	19.58KB	Share
NUZ	Proposed issue of securities - NUZ		23/12/25	26.79KB	Share
NUZ	Equity Raising Presentation	PRICE SENSITIVE	23/12/25	2.92MB	Share
NUZ	New Funding Secured for HEALEY ALS Platform Trial	PRICE SENSITIVE	23/12/25	402.91KB	Share
NUZ	Trading Halt	PRICE SENSITIVE	19/12/25	352.4KB	Share
NUZ	FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial	PRICE SENSITIVE	11/12/25	244.62KB	Share
NUZ	Neurizon Completes GMP Tablet Registration Batches	PRICE SENSITIVE	04/12/25	237.16KB	Share
NUZ	Amended Constitution		03/12/25	877.96KB	Share
NUZ	Results of Annual General Meeting		26/11/25	403.16KB	Share
NUZ	AGM Presentation		26/11/25	2.48MB	Share
NUZ	Chairman's AGM Address		26/11/25	248.21KB	Share
NUZ	Elanco executive appointed as Board Observer		26/11/25	183.09KB	Share
NUZ	Section 708A Cleansing Statement		31/10/25	323.11KB	Share
NUZ	Application for quotation of securities - NUZ		31/10/25	15.62KB	Share
NUZ	Neurizon to present Q1 FY2026 Results	PRICE SENSITIVE	31/10/25	2.53MB	Share
NUZ	Appendix 4C & Quarterly Update	PRICE SENSITIVE	29/10/25	673.42KB	Share
NUZ	Notice of Annual General Meeting/Proxy Form		23/10/25	683.66KB	Share
NUZ	Australian Patent Granted for NUZ-001	PRICE SENSITIVE	21/10/25	373.92KB	Share
NUZ	Quarterly Shareholder Update Webinar - Q1 FY2026		20/10/25	326.37KB	Share
NUZ	Neurizon to Present Poster Data at 2025 NEALS Annual Meeting		10/10/25	3.27MB	Share
NUZ	Proposed issue of securities - NUZ		08/10/25	15.04KB	Share
NUZ	Neurizon Commences Trading on OTCQB Venture Market		08/10/25	384.44KB	Share
NUZ	FDA Lifts Clinical Hold on NUZ-001	PRICE SENSITIVE	06/10/25	446.64KB	Share
NUZ	Notification regarding unquoted securities - NUZ		01/10/25	19.02KB	Share
NUZ	Section 708A Cleansing Statement		24/09/25	322.3KB	Share
NUZ	Application for quotation of securities - NUZ		23/09/25	14.51KB	Share
NUZ	R&D Tax Incentive Advance & Overseas Finding Approval	PRICE SENSITIVE	18/09/25	303.28KB	Share
NUZ	Proposed issue of securities - NUZ		18/09/25	16.61KB	Share
NUZ	Neurizon Raises $5m via Institutional Placement	PRICE SENSITIVE	18/09/25	392.46KB	Share
NUZ	Trading Halt	PRICE SENSITIVE	16/09/25	268.3KB	Share
NUZ	Change of AGM Date		01/09/25	249.67KB	Share
NUZ	Neurizon to present Q4 updates to Shareholders		26/08/25	2.43MB	Share
NUZ	Appendix 4G and Corporate Governance Statement		26/08/25	718.66KB	Share
NUZ	Appendix 4E and 2025 Annual Report	PRICE SENSITIVE	26/08/25	3.2MB	Share
NUZ	Notice of Shareholder Update Webinar		20/08/25	327.79KB	Share
NUZ	NUZ-001 Shows Long-Term Safety and Efficacy Signals in OLE	PRICE SENSITIVE	20/08/25	3.52MB	Share
NUZ	FDA Review Timeline Extended for NUZ-001 IND Clinical Hold	PRICE SENSITIVE	15/08/25	292.67KB	Share
NUZ	Neurizon Commences Manufacture of First Registration Batch		12/08/25	393.73KB	Share
NUZ	AGM Date & Director Nominations Closing Date for AGM		05/08/25	264.7KB	Share
NUZ	Appendix 4C & Quarterly Update	PRICE SENSITIVE	30/07/25	965.65KB	Share
NUZ	Neurizon Secures Loan Against 2025 R&D Tax Rebate	PRICE SENSITIVE	30/07/25	357.77KB	Share
NUZ	Neurizon Submits Clinical Hold Complete Response to FDA	PRICE SENSITIVE	25/07/25	413.76KB	Share
NUZ	Positive feedback from FDA on strategy to lift clinical hold	PRICE SENSITIVE	10/07/25	333.72KB	Share
NUZ	Presentation Materials - Licensing Agreement Webinar		02/07/25	1.32MB	Share
NUZ	Invitation to Shareholder Webinar		02/07/25	290.51KB	Share

NUZ Ethics Approval Received for NUZ-001 Oral Liquid P1 Study
13/05/26	PRICE SENSITIVE	284.8KB	Share
NUZ Final Director's Interest Notice
12/05/26		331.98KB	Share
NUZ Initial Director's Interest Notice
12/05/26		351.01KB	Share
NUZ Australian Microcap Investment Conference Presentation
11/05/26		18.86MB	Share
NUZ Neurizon Strengthens Board for the Next Growth Phase
08/05/26		297.39KB	Share
NUZ Change of Director's Interest Notices
04/05/26		269KB	Share
NUZ Neurizon investor briefing presentation
30/04/26		2.32MB	Share
NUZ Application for quotation of securities - NUZ
30/04/26		15.72KB	Share
NUZ Appendix 4C & Quarterly Update
30/04/26	PRICE SENSITIVE	763.2KB	Share
NUZ Section 708A Cleansing Statement
21/04/26		305.95KB	Share
NUZ Application for quotation of securities - NUZ
21/04/26		15.71KB	Share
NUZ Neurizon Investor Briefings Invitation
16/04/26		285.88KB	Share
NUZ Placement of Entitlement Offer Shortfall
16/04/26	PRICE SENSITIVE	293.22KB	Share
NUZ Investor Presentation - April 2026
10/04/26		1.51MB	Share
NUZ Section 708A Cleansing Statement
01/04/26		305.53KB	Share
NUZ Application for quotation of securities - NUZ
01/04/26		15.78KB	Share
NUZ NUZ-001 Data Shows Multi-Pathway Protein Clearance
01/04/26	PRICE SENSITIVE	420.88KB	Share
NUZ Change of Director's Interest Notices x4
26/03/26		1.06MB	Share
NUZ Notification of Expiry of NUZOA Listed Options
20/03/26		837.01KB	Share
NUZ Neurizon presents at HEALEY ALS Platform Trial Webinar
20/03/26		2.31MB	Share
NUZ Section 708A Cleansing Statement
19/03/26		308.29KB	Share
NUZ Application for quotation of securities - NUZ
19/03/26		15.93KB	Share
NUZ Neurizon announces leadership transition
16/03/26	PRICE SENSITIVE	255.53KB	Share
NUZ Preclinical Data in Huntington's Disease Presented at ASENT
05/03/26		478.63KB	Share
NUZ Notification of cessation of securities - NUZ
04/03/26		12.86KB	Share
NUZ Drawdown of tranche one of strategic financing facility
27/02/26		165.7KB	Share
NUZ Notification regarding unquoted securities - NUZ
27/02/26		19.29KB	Share
NUZ Cleansing Statement - Section 708A(12C)(e)
27/02/26		528.53KB	Share
NUZ Application for quotation of securities - NUZ
27/02/26		16.2KB	Share
NUZ Section 708A Cleansing Statement
27/02/26		216.27KB	Share
NUZ Neurizon Initiates Dosing in HEALEY ALS Platform Trial
26/02/26	PRICE SENSITIVE	322.45KB	Share
NUZ Appendix 4D - Half-year Financial Report - 31 December 2025
25/02/26	PRICE SENSITIVE	630.09KB	Share
NUZ Results of General Meeting
20/02/26		398.66KB	Share
NUZ General Meeting Presentation
20/02/26		4.43MB	Share
NUZ Change of Director's Interest Notice
03/02/26		273.1KB	Share
NUZ Appendix 4C & Quarterly Update
30/01/26	PRICE SENSITIVE	699.76KB	Share
NUZ Neurizon secures $6million R&D Tax Incentive Rebate
29/01/26	PRICE SENSITIVE	228.97KB	Share
NUZ Application for quotation of securities - NUZ
29/01/26		15.9KB	Share
NUZ Neurizon Completes Entitlement Offer
27/01/26	PRICE SENSITIVE	260.87KB	Share
NUZ Change of Director's Interest Notice
23/01/26		274.39KB	Share
NUZ Notification of cessation of securities - NUZ
23/01/26		12.9KB	Share
NUZ Notice of General Meeting/Proxy Form
21/01/26		903.87KB	Share
NUZ Global Trademark Protection Secured Across Key Markets
20/01/26	PRICE SENSITIVE	195.44KB	Share
NUZ Investor webinar presentation
15/01/26		2.52MB	Share
NUZ Notice of a Shareholder webinar
08/01/26		210.23KB	Share
NUZ Becoming a substantial holder
07/01/26		273.11KB	Share
NUZ Notification of cessation of securities - NUZ
06/01/26		12.93KB	Share
NUZ Entitlement Offer Opens & Despatch of Offer Booklet
05/01/26		4.6MB	Share
NUZ Section 708A Cleansing Statement
02/01/26		228.17KB	Share
NUZ Regulatory and Development Update
02/01/26	PRICE SENSITIVE	182.9KB	Share
NUZ Change of Director's Interest Notices x4
02/01/26		1.09MB	Share
NUZ Application for quotation of securities - NUZ
31/12/25		14.69KB	Share
NUZ Section 708A Cleansing Statement
23/12/25		231.1KB	Share
NUZ Application for quotation of securities - NUZ
23/12/25		15.82KB	Share
NUZ Notice under s708AA(2)(f)
23/12/25		236.44KB	Share
NUZ Proposed issue of securities - NUZ
23/12/25		19.58KB	Share
NUZ Proposed issue of securities - NUZ
23/12/25		26.79KB	Share
NUZ Equity Raising Presentation
23/12/25	PRICE SENSITIVE	2.92MB	Share
NUZ New Funding Secured for HEALEY ALS Platform Trial
23/12/25	PRICE SENSITIVE	402.91KB	Share
NUZ Trading Halt
19/12/25	PRICE SENSITIVE	352.4KB	Share
NUZ FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
11/12/25	PRICE SENSITIVE	244.62KB	Share
NUZ Neurizon Completes GMP Tablet Registration Batches
04/12/25	PRICE SENSITIVE	237.16KB	Share
NUZ Amended Constitution
03/12/25		877.96KB	Share
NUZ Results of Annual General Meeting
26/11/25		403.16KB	Share
NUZ AGM Presentation
26/11/25		2.48MB	Share
NUZ Chairman's AGM Address
26/11/25		248.21KB	Share
NUZ Elanco executive appointed as Board Observer
26/11/25		183.09KB	Share
NUZ Section 708A Cleansing Statement
31/10/25		323.11KB	Share
NUZ Application for quotation of securities - NUZ
31/10/25		15.62KB	Share
NUZ Neurizon to present Q1 FY2026 Results
31/10/25	PRICE SENSITIVE	2.53MB	Share
NUZ Appendix 4C & Quarterly Update
29/10/25	PRICE SENSITIVE	673.42KB	Share
NUZ Notice of Annual General Meeting/Proxy Form
23/10/25		683.66KB	Share
NUZ Australian Patent Granted for NUZ-001
21/10/25	PRICE SENSITIVE	373.92KB	Share
NUZ Quarterly Shareholder Update Webinar - Q1 FY2026
20/10/25		326.37KB	Share
NUZ Neurizon to Present Poster Data at 2025 NEALS Annual Meeting
10/10/25		3.27MB	Share
NUZ Proposed issue of securities - NUZ
08/10/25		15.04KB	Share
NUZ Neurizon Commences Trading on OTCQB Venture Market
08/10/25		384.44KB	Share
NUZ FDA Lifts Clinical Hold on NUZ-001
06/10/25	PRICE SENSITIVE	446.64KB	Share
NUZ Notification regarding unquoted securities - NUZ
01/10/25		19.02KB	Share
NUZ Section 708A Cleansing Statement
24/09/25		322.3KB	Share
NUZ Application for quotation of securities - NUZ
23/09/25		14.51KB	Share
NUZ R&D Tax Incentive Advance & Overseas Finding Approval
18/09/25	PRICE SENSITIVE	303.28KB	Share
NUZ Proposed issue of securities - NUZ
18/09/25		16.61KB	Share
NUZ Neurizon Raises $5m via Institutional Placement
18/09/25	PRICE SENSITIVE	392.46KB	Share
NUZ Trading Halt
16/09/25	PRICE SENSITIVE	268.3KB	Share
NUZ Change of AGM Date
01/09/25		249.67KB	Share
NUZ Neurizon to present Q4 updates to Shareholders
26/08/25		2.43MB	Share
NUZ Appendix 4G and Corporate Governance Statement
26/08/25		718.66KB	Share
NUZ Appendix 4E and 2025 Annual Report
26/08/25	PRICE SENSITIVE	3.2MB	Share
NUZ Notice of Shareholder Update Webinar
20/08/25		327.79KB	Share
NUZ NUZ-001 Shows Long-Term Safety and Efficacy Signals in OLE
20/08/25	PRICE SENSITIVE	3.52MB	Share
NUZ FDA Review Timeline Extended for NUZ-001 IND Clinical Hold
15/08/25	PRICE SENSITIVE	292.67KB	Share
NUZ Neurizon Commences Manufacture of First Registration Batch
12/08/25		393.73KB	Share
NUZ AGM Date & Director Nominations Closing Date for AGM
05/08/25		264.7KB	Share
NUZ Appendix 4C & Quarterly Update
30/07/25	PRICE SENSITIVE	965.65KB	Share
NUZ Neurizon Secures Loan Against 2025 R&D Tax Rebate
30/07/25	PRICE SENSITIVE	357.77KB	Share
NUZ Neurizon Submits Clinical Hold Complete Response to FDA
25/07/25	PRICE SENSITIVE	413.76KB	Share
NUZ Positive feedback from FDA on strategy to lift clinical hold
10/07/25	PRICE SENSITIVE	333.72KB	Share
NUZ Presentation Materials - Licensing Agreement Webinar
02/07/25		1.32MB	Share
NUZ Invitation to Shareholder Webinar
02/07/25		290.51KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 7.0¢		Change -0.002(2.78%)		Mkt cap ! $53.73M

Open	High	Low	Volume
6.8¢	7.1¢	6.8¢	408.7K

Buyers (Bids)

Vol.	Price($)
173126	6.8¢

Sellers (Offers)

Price($)	Vol.
7.0¢	133477

Last trade - 15.33pm 18/05/2026 (20 minute delay)

NUZ (ASX) Chart

NEURIZON THERAPEUTICS LIMITED - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories